Be confident of medical device market approval
The European Union is currently developing a revised regulation that addresses the requirements for medical devices and active implantable medical devices offered for sale in the EU. Once adopted, the new regulation will replace the EU’s Directive on active implantable medical devices (90/385/EEC) and the EU’s Medical Device Directive (93/42/EEC).
An active implantable medical device (AIMD) is any active medical device that is intended to be totally or partially introduced into the human body for diagnostic or therapeutic purposes, and which is intended to remain in place. AIMDs include a wide range of devices, including pacemakers, defibrillators, infusion pumps, ventricular assist systems and devices, cochlear implants and neurostimulators. Because AIMDs are designed to remain in direct contact with the body for extended periods, they are subject to rigorous standards and requirements to protect the health and safety of patients.
Directive 90/385/EEC of the European Union (EU) specifies the Essential Requirements manufacturers and importers must meet to apply the CE Mark and legally market or sell AIMDs in the EU. To demonstrate compliance with the requirements of the AIMD Directive, a manufacturer must develop technical documentation in order to properly evaluate their device. AIMD manufacturers must also establish a quality management system that complies with the Directive’s requirements.
TÜV SÜD Product Service is the world’s largest EU Notified Body for AIMDs and other medical devices.Our extensive network makes TÜV SÜD Product Service an effective single source for manufacturers seeking expertise in the testing and certification of AIMDs and other medical devices to EU requirements, as well as regulations applicable to medical devices in other major markets.
By achieving compliance with the Essential Requirements of the AIMD Directive, manufacturers may tap into the European market consisting of 500 million consumers. In addition, AIMDs bearing the CE Mark may achieve faster regulatory review and approval in other global markets.
Select Your Location
Bosnia and Herzegovina